Clinical Trials On-Line - Physican: Joseph Rosenthal

The following is a list of available studies directed by Joseph Rosenthal, MD

Search results: 4 Clinical trial(s) found (Page 1 of 1 )

Click here to generate a printer-friendly view

08165

P.I.:

Joseph Rosenthal, MD

Title:

BMT CTN Protocol 0603: A Multi-Center, Phase II Trial of Nonmyeloablative Conditioning (NST) and Transplantation of Partially HLA - Mismatched Bone Marrow for Patients with Hematologic Malignancies

Click here for

Full Eligibility Criteria

08132

P.I.:

Joseph Rosenthal, MD

Title:

BMT CTN 0601: Unrelated Donor Hematopoietic Cell Transplantation for Children with Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen

Click here for

Full Eligibility Criteria

06178

P.I.:

Joseph Rosenthal, MD

Title:

BMT CTN #0501: Multi-Center, Open Label, Randomized Trial Comparing Single Versus Double Umbilical Cord Blood Transplantation in Pediatric Patients with High Risk Leukemia and Myelodysplasia

Click here for

Full Eligibility Criteria

04199

P.I.:

Joseph Rosenthal, MD

Title:

Allogeneic Stem Cell Transplantation with a Novel Conditioning Therapy Helical Tomotherapy, Melphalan, and Fludarabine in Hematological Malignancies

Click here for

Full Eligibility Criteria

City of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.

City of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.

We subscribe to the HONcode of the Healthcare on the Net Foundation.

City of Hope

Page Title

Global Navigation